Skip to content

Vascular Closure

Rapid haemostasis for arterial and venous access sites
The portfolio of vascular closure products provides rapid haemostasis for interventional and electrophysiology procedures to help clinicians reduce the risk of complications, improve patient satisfaction and enable early ambulation which allows a same day discharge consideration.

Optimising Vascular Access Management
Enables same day discharge following catheter-based procedures with VASCADE MVP® venous vascular closure system (VVCS).1​
Helps reduce the risk of access site complications with VASCADE® vascular closure system (VCS), as demonstrated in the RESPECT Clinical Trial.2

Haemonetics Vascular Closure

Learn more at these events

1. Natale A, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: The AMBULATE Trial. JACC Clin Electrophysiol 2020; 6(1):111-124.

2. Hermiller JB, A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients Journal of Invasive Cardiology 2015;27(3):129-136.


Connect with Vascular Closure

Haemonetics Vascular Closure LinkedIn    Haemonetics Vascular Closure Twitter

Not all products are available in all markets.